Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: comparison with metaphase banding …

A Cuneo, R Bigoni, B Emmanuel, E Smit, GM Rigolin… - Leukemia, 1998 - nature.com
In order to analyze the efficiency of interphase FISH for the detection and monitoring of Ph+
cells in chronic myelogenous leukemia (CML) under interferon (IFN) treatment, the following …

Fluorescence in situ hybridization studies of interphase nuclei for assessing response to therapy in patients with chronic myeloid leukemia

Y Kobzev, E Domracheva, N Khoroshko… - Cancer genetics and …, 1998 - Elsevier
We used two-color fluorescence in situ hybridization (FISH) to detect BCR/ABL fusion in
interphase nuclei in bone marrow of 17 patients with chronic myeloid leukemia (CML) before …

Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia

GW Dewald, WA Wyatt, AL Juneau… - Blood, The Journal …, 1998 - ashpublications.org
We investigated a new method using fluorescence in situ hybridization and DNA probes that
span the common breakpoints of t (9; 22)(q34; q11. 2) and that detect double BCR/ABL …

Clinical detection of BCR-ABL fusion by in situ hybridization in chronic myelogenous leukemia

A Amiel, S Yarkoni, M Fejgin, E Gaber, A Nagler… - Cancer genetics and …, 1993 - Elsevier
We describe the use of the fluorescence in situ hybridization (FISH) technique to detect
residual Philadelphia chromosome-positive (Ph+) cells in a patient with blastic phase …

Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ …

M Yanagi, K Shinjo, A Takeshita, T Tobita, K Yano… - Leukemia, 1999 - nature.com
Philadelphia (Ph) chromosome or the bcr/abl fusion gene is the hallmark of chronic myeloid
leukemia (CML) and serves as a prognostic marker during its treatment. Its detection has …

Interphase FISH for follow-up of Philadelphia chromosome-positive chronic myeloid leukemia treatment

N Douet-Guilbert, F Morel, T Le Charpentier… - Anticancer …, 2004 - ar.iiarjournals.org
Background: Several attempts have been made to determine whether interphase
fluorescence in situ hybridization (I-FISH) on bone marrow or peripheral blood specimens is …

Comparison of chromosome banding analysis, interphase-and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic …

C Schoch, S Schnittger, S Bursch, D Gerstner… - Leukemia, 2002 - nature.com
For the diagnosis of CML and for monitoring of treatment response the detection of the t (9;
22)(q34; q11) or the BCR-ABL rearrangement is necessary. Chromosome banding analysis …

Improved sensitivity of BCR-ABL detection: a triple-probe three-color fluorescence in situ hybridization system

PB Sinclair, AR Green, C Grace… - Blood, The Journal of …, 1997 - ashpublications.org
Chronic myeloid leukemia is a clonal stem cell disorder associated with the Philadelphia
(Ph) translocation [t (9; 22)(q34; q11)]. As a result of the Ph translocation, parts of the ABL …

Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia

CM Seong, S Giralt, H Kantarjian, J Xu… - Journal of clinical …, 2000 - ascopubs.org
PURPOSE: Standard G-band cytogenetic analysis (CG) provides information on
approximately 25 metaphases for monitoring the presence of Philadelphia chromosome …

Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow …

S Akel, A Kolialexi, A Mavrou… - Clinical & Laboratory …, 2002 - Wiley Online Library
Conventional cytogenetic analysis (CCA) is the standard method for monitoring of the
Philadelphia (Ph) chromosome in chronic myeloid leukemia (CML). Evaluation of breakpoint …